October 07, 2021
A Delaware federal lawsuit accusing a pharmaceutical executive of spearheading a Ponzi scheme that duped investors out of millions was more than just a business-gone-bad dispute, as emotions ran high due to the nature of proceedings, Cozen O'Connor attorneys who scored a win for investors said.